The decision marks a significant win for Japan, as China is its largest overseas market for seafood, accounting for over ...

Israel has stated that its attack on Iran is aimed at destroying its capabilities of producing nuclear weapons, alleging that the uranium enrichment sites within Iran are producing materials to make a ...

Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable of reaching targets beyond the liver. The Japanese drugmaker is best ...

In tandem with Enhertu’s inclusion in China’s national insurance program, Daiichi Sankyo is planting a foothold in local production. Daiichi will invest 1.1 billion Chinese yuan ($152 million ...

Tokyo Electric Power Company (TEPCO), which runs the Fukushima Dai-ichi nuclear plant, has introduced a massive robot to retrieve the first fuel sample from a reactor. This comes 13 years after a ...

Czech scientists have received a US patent for their discovery that a polycrystalline-diamond coating can significantly protect fuel rods against corrosion during both normal reactor operation and ...

The decommissioning process for the Fukushima Daiichi site and surroundings is scheduled to be completed by 2051. It will require many innovations, and careful planning. Here are some of the details ...

Within a few years, these last spent fuel rods can then be safely transported off-site for storage, reprocessing and the manufacturing of fresh reactor fuel. That’s projected to be 2026 for Unit ...

The damaged nuclear reactors at Japan's Fukushima Daiichi nuclear power plant, which was crippled by a March 11, 2011 tusnami. ... Parts of the control-rod drive mechanism, ...

Overcoming technical hurdles to retrieve hazardous material. The Fukushima Daiichi nuclear plant, which suffered one of the worst nuclear disasters in history after a 9.0-magnitude earthquake ...

In the second setback for the HER3 field in days, the FDA has rejected Daiichi Sankyo’s Merck & Co.-partnered antibody-drug conjugate (ADC) patritumab deruxtecan. The drug, also known as HER3 ...